| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5588120 | Journal of Diabetes and its Complications | 2016 | 21 Pages |
Abstract
Our results suggest that both sitagliptin and SU reduce albuminuria as an add-on therapy to metformin, but that sitagliptin may provide greater reductions in albuminuria independent of glycemic control when compared to SU. Larger population studies are required to further explore this.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Inbal Goldshtein, Avraham Karasik, Cheli Melzer-Cohen, Samuel S. Engel, Shengsheng Yu, Ofer Sharon, Kimberly Brodovicz, Noga Gadir, Harvey L. Katzeff, Larry Radican, Gabriel Chodick, Varda Shalev, Kaan Tunceli,